Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.

MLA

Sutter, Damian, et al. “Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.” Scientific Reports, vol. 9, no. 1, June 2019, p. 9269. EBSCOhost, https://doi.org/10.1038/s41598-019-45759-y.

APA

Sutter, D., Dzhonova, D. V., Prost, J.-C., Bovet, C., Banz, Y., Rahnfeld, L., Leroux, J.-C., Rieben, R., Vögelin, E., Plock, J. A., Luciani, P., Taddeo, A., & Schnider, J. T. (2019). Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival. Scientific Reports, 9(1), 9269. https://doi.org/10.1038/s41598-019-45759-y

Chicago

Sutter, Damian, Dzhuliya V Dzhonova, Jean-Christophe Prost, Cedric Bovet, Yara Banz, Lisa Rahnfeld, Jean-Christophe Leroux, et al. 2019. “Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.” Scientific Reports 9 (1): 9269. doi:10.1038/s41598-019-45759-y.